Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.

Erratum to: Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group / Mercadante, Sebastiano; Marchetti, Paolo; Cuomo, Arturo; Mammucari, Massimo; Caraceni, Augusto; Mediati, RD; Caruselli, A; Costanzi, A; Bracchi, P; Dodaro, L; Contu, V; Fora, G; Veronese, B; Alu, M; Chiurazzi, B; Sgarlata, M; Kasa, A; Donelli, E; Silvestro, S; Romano, C; Ghidoni, S; Palermo, L; Pisanu, GM; Imperatori, L; Diacciati, S; Samolsky Dekel, Boaz Gedaliahu; Bruno, E; Saulle, S; Bonotto, M; De Santis, S; Tammaro, D; Ginocchi, L; Zampieri, M; Fioroni, I; Gallo, G; Saber, B; Dauri, M; Airoldi, M; Azzarello, G; Bandera, M; Blasi, L; Carteni, G; Costanzo, V; Degiovanni, D; Fusco, F; Guardamagna, V; Iaffaioli, V; Lazzari, M; Liguori, S; Lorusso, V; Mameli, S; Mattioli, R; Mazzei, T; Melotti, RM; Menardo, V; Miotti, D; Moroso, S; Natoli, S; Orsetti, R; Papa, A; Ricci, S; Sabato, AF; Scelzi, E; Sofia, M; Tonini, G; Valle, A. - In: SUPPORTIVE CARE IN CANCER. - ISSN 0941-4355. - ELETTRONICO. - 24(2):(2017), pp. 961-968. [10.1007/s00520-017-3739-z]

Erratum to: Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group

SAMOLSKY DEKEL, BOAZ GEDALIAHU;MELOTTI, RITA MARIA;
2017

Abstract

Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.
2017
Erratum to: Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group / Mercadante, Sebastiano; Marchetti, Paolo; Cuomo, Arturo; Mammucari, Massimo; Caraceni, Augusto; Mediati, RD; Caruselli, A; Costanzi, A; Bracchi, P; Dodaro, L; Contu, V; Fora, G; Veronese, B; Alu, M; Chiurazzi, B; Sgarlata, M; Kasa, A; Donelli, E; Silvestro, S; Romano, C; Ghidoni, S; Palermo, L; Pisanu, GM; Imperatori, L; Diacciati, S; Samolsky Dekel, Boaz Gedaliahu; Bruno, E; Saulle, S; Bonotto, M; De Santis, S; Tammaro, D; Ginocchi, L; Zampieri, M; Fioroni, I; Gallo, G; Saber, B; Dauri, M; Airoldi, M; Azzarello, G; Bandera, M; Blasi, L; Carteni, G; Costanzo, V; Degiovanni, D; Fusco, F; Guardamagna, V; Iaffaioli, V; Lazzari, M; Liguori, S; Lorusso, V; Mameli, S; Mattioli, R; Mazzei, T; Melotti, RM; Menardo, V; Miotti, D; Moroso, S; Natoli, S; Orsetti, R; Papa, A; Ricci, S; Sabato, AF; Scelzi, E; Sofia, M; Tonini, G; Valle, A. - In: SUPPORTIVE CARE IN CANCER. - ISSN 0941-4355. - ELETTRONICO. - 24(2):(2017), pp. 961-968. [10.1007/s00520-017-3739-z]
Mercadante, Sebastiano; Marchetti, Paolo; Cuomo, Arturo; Mammucari, Massimo; Caraceni, Augusto; Mediati, RD; Caruselli, A; Costanzi, A; Bracchi, P; Dodaro, L; Contu, V; Fora, G; Veronese, B; Alu, M; Chiurazzi, B; Sgarlata, M; Kasa, A; Donelli, E; Silvestro, S; Romano, C; Ghidoni, S; Palermo, L; Pisanu, GM; Imperatori, L; Diacciati, S; Samolsky Dekel, Boaz Gedaliahu; Bruno, E; Saulle, S; Bonotto, M; De Santis, S; Tammaro, D; Ginocchi, L; Zampieri, M; Fioroni, I; Gallo, G; Saber, B; Dauri, M; Airoldi, M; Azzarello, G; Bandera, M; Blasi, L; Carteni, G; Costanzo, V; Degiovanni, D; Fusco, F; Guardamagna, V; Iaffaioli, V; Lazzari, M; Liguori, S; Lorusso, V; Mameli, S; Mattioli, R; Mazzei, T; Melotti, RM; Menardo, V; Miotti, D; Moroso, S; Natoli, S; Orsetti, R; Papa, A; Ricci, S; Sabato, AF; Scelzi, E; Sofia, M; Tonini, G; Valle, A
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/591014
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 37
social impact